Medicine and Dentistry
All Cause Mortality
43%
Ambulance
16%
Anemia
10%
Antiarrhythmic Agent
7%
Anticoagulant Therapy
6%
Anticoagulation
7%
Antithrombotic
22%
Aortic Valve Replacement
8%
Apixaban
13%
Atrial Fibrillation
76%
Attributable Risk
9%
B-Cell Chronic Lymphocytic Leukemia
6%
Beta Adrenergic Receptor Blocking Agent
26%
Bilirubin
6%
Biological Marker
9%
Blood Pressure
7%
Brain Ischemia
12%
Breast Cancer
13%
Cardiac Resynchronization Therapy
17%
Cardiovascular Disease
34%
Cardiovascular Mortality
11%
Carvedilol
14%
CHA2DS2-VASc Score
6%
Chronic Kidney Disease
6%
Chronic Obstructive Pulmonary Disease
28%
Cohort Analysis
42%
Colorectal Cancer Screening
11%
Comorbidity
28%
Complication
6%
Coronary Artery Bypass Graft
12%
COVID-19
19%
Cumulative Incidence
8%
Dabigatran
7%
Defibrillation
18%
Defibrillator
17%
Diabetes
22%
Diabetes Mellitus
11%
Diffuse Large B-Cell Lymphoma
8%
Diseases
26%
Electrocardiogram
15%
Endocarditis
8%
Faintness
9%
Follow up
57%
Fracture
7%
Hazard Ratio
100%
Heart Arrest
24%
Heart Failure
77%
Heart Rate
6%
Hemodialysis
10%
Hemoglobin
7%
Hodgkin's Lymphoma
6%
Hypertension
8%
Hypokalemia
11%
Hysterectomy
6%
Implantable Automatic Defibrillator
21%
Infective Endocarditis
38%
Intensive Care
13%
Ischemic Heart Disease
11%
Left Bundle Branch Block
16%
Low Drug Dose
6%
Lymphoma
8%
Major Bleeding
6%
Maturity Onset Diabetes of the Young
11%
Measurement
9%
Meta-Analysis
7%
Metoprolol
6%
Monotherapy
8%
Mortality Rate
8%
Myocardial Infarction
51%
Narcotic Analgesic Agent
6%
Obesity
14%
Observational Study
7%
Odds Ratio
36%
Opiate
7%
Out of Hospital Cardiac Arrest
68%
Patient Registry
6%
Patient with Diabetes
6%
Physical Activity
6%
Population
6%
Population Research
8%
Potassium
28%
Predictor
14%
Prevalence
11%
Prognosis
7%
Proportional Hazards Model
37%
Proton-Pump Inhibitor
6%
QRS Interval
8%
Renal Replacement Therapy
6%
Resuscitation
37%
Rhythm
19%
Rivaroxaban
15%
Serum
17%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Sinus Lift
9%
Socioeconomic Status
12%
Thromboembolism
20%
Typical Antipsychotic
10%
Venous Thromboembolism
17%
Vitamin K Antagonist
27%
Agricultural and Biological Sciences
Arteries
5%
B Cell
11%
Biomarkers
6%
Cardiovascular System
11%
Cohort Studies
33%
Computed Tomography
5%
Confidence Interval
84%
Cumulative Risk
6%
Epicardial Coronary Arteries
10%
Measurement
5%
Myocardial Infarction
32%
Odds Ratio
26%
Plasminogen Activator
5%
Prevalence
6%
Receptors
5%
Regression Analysis
12%
Risk Factors
21%
Rivaroxaban
14%
Social Inequality
9%
Vitamin K Antagonist
24%